NEFL and frontotemporal dementia: NfL, a cytoskeletal scaffold protein released by neurons into the CSF and blood upon damage, can serve as a biomarker for identifying individuals at risk of progressing from the presymptomatic stage to the symptomatic stage of genetic FTD [278].